Page last updated: 2024-09-05

dabigatran and Hemorrhage, Uterine

dabigatran has been researched along with Hemorrhage, Uterine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Barnathan, E; Freedman, A; Larbi, L; Rao, G; Shoaibi, A; Truong, HQ; Wang, L; Weaver, J; Wildgoose, P; Wu, S; Yuan, Z1
Anderson, A; Eworuke, E; Gassman, A; Hou, L; Huang, TY; Moeny, D; Waldron, P; Wong, HL; Zhang, R1
Dilcher, B; Hayward, I; Kline, J; Pagenhardt, J; Quedado, K1
Ferreira, M; Feuring, M; Fraessdorf, M; Huisman, MV; Klok, FA1
Goodrich, ST; Patel, SA1
Artunc, F; Baumann, D; Haap, M; Jaschonek, K; Krämer, B; Peter, A; Rettig, I; Schreieck, J; Tsaousidis, C; Wallwiener, D1
Conard, J; Horellou, MH; Samama, MM1

Reviews

1 review(s) available for dabigatran and Hemorrhage, Uterine

ArticleYear
Comparative Risk Assessment of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants: A Network Study Across Four Observational Databases in the USA.
    Drug safety, 2021, Volume: 44, Issue:4

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Humans; Male; Observational Studies as Topic; Pyridones; Risk Assessment; Rivaroxaban; Uterine Hemorrhage; Venous Thromboembolism; Warfarin

2021

Other Studies

6 other study(ies) available for dabigatran and Hemorrhage, Uterine

ArticleYear
Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin.
    Drug safety, 2021, Volume: 44, Issue:7

    Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Humans; Male; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Uterine Hemorrhage; Warfarin

2021
Incidence of abnormal uterine bleeding in a multicenter implementation study using apixaban and rivaroxaban to treat venous thromboembolism.
    Thrombosis research, 2021, Volume: 204

    Topics: Anticoagulants; Dabigatran; Female; Humans; Incidence; Pyrazoles; Pyridones; Rivaroxaban; Uterine Hemorrhage; Venous Thromboembolism

2021
Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism.
    Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:9

    Topics: Adolescent; Adult; Anticoagulants; Clinical Trials as Topic; Contraceptives, Oral, Hormonal; Dabigatran; Factor Xa Inhibitors; Female; Humans; Incidence; Menorrhagia; Middle Aged; Multicenter Studies as Topic; Uterine Hemorrhage; Venous Thromboembolism; Vitamin K; Warfarin; Young Adult

2018
Endometrial adenocarcinoma following supracervical hysterectomy managed with radiation due to dabigatran etexilate.
    Military medicine, 2014, Volume: 179, Issue:3

    Topics: Adenocarcinoma; Aged; Benzimidazoles; Dabigatran; Endometrial Neoplasms; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Hysterectomy; Positron-Emission Tomography; Pyridines; Radiotherapy, Conformal; Tomography, X-Ray Computed; Uterine Hemorrhage

2014
[Vaginal bleeding as symptom of a medical emergency--pitfalls of therapy with new oral anticoagulants - case 5/2014].
    Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:30

    Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Diagnosis, Differential; Emergencies; Female; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Uterine Hemorrhage

2014
[Pregnancy and venous thromboembolism. North-American and European guidelines. American College of Chest Physicians].
    Journal des maladies vasculaires, 2009, Volume: 34, Issue:5

    Topics: Abnormalities, Drug-Induced; Adult; Anticoagulants; Benzimidazoles; Blood Loss, Surgical; Cesarean Section; Contraindications; Dabigatran; Europe; Evidence-Based Medicine; Female; Fetus; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; Morpholines; Polysaccharides; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Pyridines; Rivaroxaban; Societies, Medical; Thiophenes; Thrombophilia; United States; Uterine Hemorrhage; Venous Thromboembolism; Warfarin

2009